scholarly article | Q13442814 |
P50 | author | Karen H Costenbader | Q87706447 |
Elizabeth W Karlson | Q98839527 | ||
P2093 | author name string | Matthew H Liang | |
Elizabeth Wright | |||
P2860 | cites work | The Measurement of Observer Agreement for Categorical Data | Q26778373 |
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort | Q33915430 | ||
How accelerated atherosclerosis in SLE has changed our management of the disorder | Q33915484 | ||
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
The treatment of unrelated disorders in patients with chronic medical diseases | Q34468642 | ||
Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis | Q34561309 | ||
Can comorbidity be measured by questionnaire rather than medical record review? | Q40940629 | ||
Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients | Q43637712 | ||
The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes | Q44009091 | ||
The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients | Q44593960 | ||
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study | Q44652580 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 983-988 | |
P577 | publication date | 2004-12-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Cardiac risk factor awareness and management in patients with systemic lupus erythematosus | |
P478 | volume | 51 |
Q36726386 | Atherosclerosis and inflammation: insights from rheumatoid arthritis |
Q87998045 | Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus |
Q37800055 | Defining quality of care in rheumatology: The American College of Rheumatology white paper on quality measurement |
Q52592135 | Lipid Testing and Statin Prescription among Medicaid Recipients with Systemic Lupus Erythematosus, Diabetes Mellitus and the General Medicaid Population. |
Q33730536 | Management of cardiovascular complications in systemic lupus erythematosus |
Q36915663 | Management of dyslipidemia in children and adolescents with systemic lupus erythematosus |
Q48434991 | Physical activity in patients with systemic lupus erythematosus and matched controls |
Q34156600 | Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry |
Q38149850 | Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand? |
Q64926763 | Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus. |
Q57985176 | Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry |
Q34630261 | Systemic lupus erythematosus and cardiac risk factors: medical record documentation and patient adherence |
Q37113440 | Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus |
Search more.